Silence Therapeutics plc Operating Lease Right-of-Use Assets
Silence Therapeutics plc (SLNCF) had Operating Lease Right-of-Use Assets of $117.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $117.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $142.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $167.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $192.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $117.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $142.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $167.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $192.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $58.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $107.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $157.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $370.00K 10-K · filed 2025-02-27 |